...ViaCyte to Develop Immune-evasive Pancreatic Cells" ). Also in September, ViaCyte raised $10 million from W.L. Gore...

...ViaCyte to Develop Immune-evasive Pancreatic Cells" ). Also in September, ViaCyte raised $10 million from W.L. Gore...

...up to three, six and 12 months of treatment. GI Dynamics Inc. (ASX:GID), Lexington, Mass. W.L. Gore...

...could prevent tissue overgrowth that occurs with vascular grafts. Angiotech Pharmaceuticals Inc. (TSE:ANP), Vancouver, B.C. W.L. Gore...